Eczema Free Forever™

Drug for refractory psoriatic arthritis shows promise in clinical trial

In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided…
Eczema / Psoriasis News From Medical News Today

Eczema Free Forever™